Vaginal and bladder health
Assessment first
The symptoms women are rarely prepared for
Nobody Told Me Menopause Could Affect My Vagina, Bladder and Sex Life
The intimate symptoms women are often least prepared for—and why they can be connected without having the same diagnosis.
You may expect a hot flush or a broken night. You may not expect urine to sting when a test is negative, sex to hurt when desire is still present, or the vulva to burn after another treatment for presumed thrush. What if these are not four unrelated problems?
Key takeaways
- ✓Vaginal, vulval, urinary and sexual symptoms may be connected, but they do not all have the same cause.
- ✓Desire, arousal and lubrication are distinct. Dryness does not prove that desire has disappeared.
- ✓Painful sex is a symptom, not a diagnosis or an unavoidable price of ageing.
- ✓A confirmed bacterial UTI is different from urgency or burning that feels like a UTI.
- ✓Treatment should begin with the symptom and diagnosis, not with a procedure.
Intimate symptoms may belong in the same conversation without sharing the same diagnosis.
Executive summary
The information gap below the waist
The central distinction
Menopause-related change may connect the symptoms. Connection is not diagnosis. Recognition should open a careful assessment, not close it.
A connected framework
One phrase connects more than many women expect
Genitourinary syndrome of menopause, or GSM, brings genital, urinary and sexual symptoms into one clinical frame.
Vulva and vagina
Dryness, reduced lubrication, soreness, irritation and fragile tissue may occur. External skin symptoms still need their own differential diagnosis.
Urethra and bladder
Urgency, frequency, discomfort when passing urine and recurrent UTI may appear in the same life stage.
Sexual comfort
Pain, friction and fear of pain can interact with lubrication and pelvic-floor guarding without defining desire.
Fluctuating and lower oestrogen can affect hormone-responsive tissue resilience, moisture, elasticity, vaginal pH and the environment around the urethra and bladder. This explains a possible connection; it does not make GSM the answer to every symptom.The term is helpful because older language often reduced the issue to “atrophy” or vaginal dryness alone. A connected framework acknowledges external vulval discomfort, urinary symptoms and sexual pain without suggesting that every person experiences all of them. Symptoms may begin during perimenopause, become clearer later or persist after vasomotor symptoms improve.Biology also does not determine how troublesome a change will be. A mild physical change may matter greatly to one person and not at all to another. Treatment is not required simply because ageing has occurred; the relevant questions are whether there is a health concern, whether symptoms affect the person’s life and whether an option fits her priorities.The same person may notice different symptoms at different times. Dryness can exist without urinary urgency; urgency can occur without pain; painful penetration can have more than one contributor. A syndrome describes a recognised collection of possibilities, not a checklist that must be completed. This is why a symptom-led conversation is more useful than asking a reader to decide whether she “has GSM” from an article.For clinicians and patients alike, the most reliable starting point is descriptive rather than diagnostic: name the sensation, identify the location, notice the pattern and then decide what information is still needed.
Three conversations women rarely realise belong together
“I am aroused—so why am I still dry?”
“Why does sex suddenly hurt?”
“Why does it burn or sting?”
UTI—or symptoms that feel exactly like one?
NHS menopause information explicitly recognises both more UTIs and UTI-like symptoms. A confirmed bacterial infection is not the same as urgency, frequency or burning without confirmation. Infection needs appropriate treatment; repeated symptoms without clarity may need a wider review.| Pattern | What it means | Why context matters |
|---|---|---|
| Confirmed UTI | Bacterial infection supported by the clinical picture and testing where indicated | Appropriate antibiotic treatment should not be delayed or dismissed as hormonal |
| Recurrent UTI | At least 2 UTIs in 6 months or 3 in 12 months under NICE | Previous cultures, sensitivities and prevention options become relevant |
| UTI-like symptoms | Burning, urgency or frequency without a confirmed infection | GSM, overactive bladder, irritation, pelvic-floor dysfunction and other causes may resemble infection |
When “thrush” keeps coming back
Itching, burning and soreness are non-specific. Candidiasis can cause them, but so can bacterial vaginosis, GSM, contact dermatitis, lichen sclerosus, other vulval skin conditions, sexually transmitted infection where relevant and persistent vulval pain.Repeated or failed treatment changes the question. Over-the-counter treatment may be reasonable in familiar, uncomplicated circumstances, but when the expected response does not happen, continuing to treat the same guess can irritate already sensitive tissue and postpone a more useful examination or test.RCOG advises assessment for vulval symptoms and lists lichen sclerosus, dermatitis, vulval atrophy and candidiasis among possible causes. Lichen sclerosus deserves particular attention because it can occur after menopause, may produce itching, soreness, fissures or visible architectural change, and needs its own treatment and follow-up. It is not another name for GSM.Swabs, examination or other tests are not a self-diagnosis decision tree; they are tools selected according to the presentation. The practical message is simple: recurrent symptoms deserve a fresh question rather than automatic repetition of the last answer.Visible change deserves attention
Persistent white patches, thickening, altered architecture, fissures, ulcers, lesions or continuing colour and texture change should be examined rather than repeatedly self-treated.
The pelvic floor may be guarding, not simply weak
Pelvic-floor dysfunction is not one problem. Reduced strength or support may contribute to leakage or prolapse. Overactivity, tenderness, poor coordination or guarding may contribute to entry pain, urgency or difficulty relaxing.Pregnancy and birth history, constipation, chronic cough, surgery, ageing, body weight, connective tissue, pain and several other factors may matter. Menopause may occur at the same life stage as pelvic-floor symptoms without being their sole cause.A pelvic-health physiotherapist can assess contraction, relaxation, coordination, tenderness and the tasks that produce symptoms. The aim may be strength, release, coordination or a combination. Generic strengthening is not a substitute for assessment when pain, guarding or complex urinary symptoms are present.“What if I am already taking HRT?”
Systemic HRT circulates through the body and may help symptoms such as hot flushes, sleep disruption or mood change. Local vaginal oestrogen is used in and around the vagina for genitourinary symptoms. They are not simply interchangeable versions of the same treatment.NICE recommends offering vaginal oestrogen for menopause-associated genitourinary symptoms, including to people already using systemic HRT. It may be used alone or in combination with a non-hormonal vaginal moisturiser or lubricant. Local symptoms can therefore continue even when systemic treatment is helping symptoms elsewhere.Vaginal oestrogen is absorbed locally, with minimal absorption into the bloodstream compared with systemic HRT. Suitability, preparation and review still depend on the individual; this article cannot provide a personal prescribing decision.People with a personal history of breast cancer need a specific discussion. NICE recommends non-hormonal moisturisers or lubricants first and allows vaginal oestrogen to be considered when symptoms continue. People taking aromatase inhibitors should make decisions with a breast-cancer specialist because recurrence risk, current treatment and personal priorities all matter.The treatment conversation should be bigger than lubricant
- Locate and describe the symptom. External or internal, urinary or genital, entry pain or deep pain?
- Consider other causes. Infection, irritation, skin disease, bladder conditions and pelvic-floor dysfunction may need specific care.
- Remove avoidable irritants. Perfumed washes, douches, wipes and repeated unneeded topical products can worsen symptoms.
- Use non-hormonal measures where suitable. Lubricants reduce friction; vaginal moisturisers support ongoing moisture.
- Discuss vaginal oestrogen where appropriate. NICE recommends it for menopausal genitourinary symptoms, including in people already using systemic HRT.
- Address pelvic-floor function. Physiotherapy may help pain, guarding, leakage, pressure or coordination problems.
- Treat the diagnosis. Confirmed infection and vulval skin disease have their own management.
Local and systemic HRT are not interchangeable
Systemic HRT may help symptoms across the body. Local vaginal oestrogen targets genitourinary symptoms and may be offered alongside systemic HRT. Personal history, including breast-cancer treatment, requires an individual discussion.
NICE also includes selected prescription alternatives for particular circumstances. Vaginal prasterone may be considered when vaginal oestrogen or non-hormonal moisturisers or lubricants have been ineffective or are not tolerated. Oral ospemifene may be considered when locally applied treatments are impractical. These are prescribing discussions, not universal next steps.The best plan may be simple, but it may also need more than one element because more than one mechanism can coexist. Improving tissue comfort will not by itself treat a bacterial infection, a vulval dermatosis or a guarded pelvic floor.
What about laser, PRP and other intimate procedures?
Procedures should come after a clear symptom history and diagnostic assessment. NICE says vaginal laser should not be offered for menopausal genitourinary symptoms except in a randomised controlled trial. RCOG likewise advises research-only use until more robust evidence is available.PRP, polynucleotides, fillers, exosomes and other interventions differ in technique and intended outcome. A proposed biological mechanism is not proof of durable improvement. They do not replace investigation, established medical management, pelvic-floor care or treatment of infection and skin disease.Five things women should not be expected to simply tolerate
Persistent pain during sex
Common does not mean inevitable. Continuing pain deserves a location-based history and appropriate assessment.
Recurrent urinary symptoms without clarity
Repeated symptoms need enough context to distinguish infection, UTI-like symptoms and other bladder or pelvic-floor causes.
Ongoing vulval soreness or itching
Persistent external symptoms and visible change should not be hidden inside the broad word “vaginal”.
Another failed treatment for presumed infection
When the expected response does not happen, repeating the same assumption can irritate tissue and delay diagnosis.
Bleeding automatically blamed on dryness
Bleeding may have a benign explanation, but postmenopausal bleeding still requires assessment rather than assumption.
This does not mean every brief or mild symptom needs intervention. It means symptoms that persist, recur, worsen or affect daily life deserve a proper conversation.
How to prepare for a useful appointment
Specific language can turn “something feels wrong down there” into information a clinician can use. Before an appointment, note:- where the symptom occurs: vulva, vagina, urethral area, bladder or deeper pelvis;
- what it feels like: dryness, itch, burn, sting, pressure, entry pain or deep pain;
- when it began, whether it is constant and what appears to trigger it;
- whether there is discharge, odour, bleeding, a fissure or visible skin change;
- urinary frequency, urgency, night waking and any urine-test results;
- products, medicines, systemic HRT and recent self-treatment;
- whether earlier treatment helped, did nothing or made symptoms worse;
- the outcome that matters most to you.
Symptoms that deserve assessment
Arrange assessment for persistent or worsening pain, continuing painful sex, recurrent confirmed UTI, repeated UTI-like symptoms, difficulty passing urine, unusual discharge or odour, visible vulval skin change, fissures, ulcers or lesions, or symptoms that do not respond as expected.
Any vaginal bleeding after menopause should be checked, even if it happens once or is only spotting or pink or brown discharge.
What should happen next?
A good consultation does not assume that the absence of hot flushes means intimate health is fine. It also does not assume that every symptom requires hormonal treatment or a procedure.The clinician may begin with the history and location, then decide whether examination, urine testing, swabs, review of medicines or referral would add useful information. The sequence should match the problem rather than a standard sales pathway.Listen → locate → consider alternatives → examine or test where indicated → explain options → decide together.
This sequence protects against both dismissal and over-treatment. It recognises the hormonal connection without allowing it to erase infection, dermatology, pelvic-floor function or the person’s own goals.
The conversation women deserve
Many women have been prepared for menopause above the waist and left unprepared for what may happen below it. The answer is not to label every intimate symptom as menopause. It is also not to accept pain, burning, recurrent urinary problems or sexual discomfort in silence.Listen → locate the symptom → consider hormonal and non-hormonal causes → examine or test where indicated → explain the options → make a shared decision.Sexual comfort remains a legitimate part of healthcare, but sex is not an obligation and treatment is not required to meet someone else’s expectation. Bladder symptoms deserve attention without being trivialised as an inevitable inconvenience. Vulval skin deserves examination when it changes. Each of these principles returns agency to the person experiencing the symptom.Once a symptom is named accurately, embarrassment has less room to control the conversation—and care can begin with what is actually happening rather than with a guess. The goal is not to make every intimate change alarming. It is to make accurate language, proportionate assessment and realistic choices available.
Educational only. Not a diagnosis or medical advice. Suitability is confirmed after consultation and assessment. Results vary. Not a cure.
Clear answers
Frequently asked questions
Can menopause affect the bladder?
Yes. Urgency, frequency, discomfort and recurrent UTI may occur, but infection, overactive bladder, pelvic-floor dysfunction and other conditions can produce similar symptoms.
Can menopause cause UTI-like symptoms?
Yes. NHS information recognises symptoms that feel like a UTI. Testing and assessment may be needed because the sensation does not prove that infection is present or absent.
Can sex hurt even if I still want sex?
Yes. Desire and lubrication are distinct. Dry or tender tissue and pelvic-floor guarding may contribute, while infection, skin disease and other causes should also be considered.
Can local symptoms persist while taking HRT?
Yes. NICE recommends vaginal oestrogen for menopausal genitourinary symptoms, including where systemic HRT is already being used, when clinically appropriate.
How do I know if it is GSM or thrush?
Symptoms overlap. Recurrent, persistent or treatment-resistant burning, itching or soreness is a reason for examination or testing rather than another assumption.
When should vulval symptoms be examined?
Persistent itching, pain, fissures, ulcers, lesions or changes in colour, texture or normal architecture should be examined.
